Shell Companies
Build Your Comparison
Side-by-side financial analysisStock Comparison
FVN vs GS vs JPM vs MS vs BAC
Revenue, margins, valuation, and 5-year total return — side by side.
Financial - Capital Markets
Banks - Diversified
Financial - Capital Markets
Banks - Diversified
FVN vs GS vs JPM vs MS vs BAC — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Shell Companies | Financial - Capital Markets | Banks - Diversified | Financial - Capital Markets | Banks - Diversified |
| Market Cap | $82M | $337.53B | $896.00B | $340.97B | $422.78B |
| Revenue (TTM) | $0.00 | $125.10B | $280.33B | $114.98B | $191.57B |
| Net Income (TTM) | $288K | $17.18B | $57.05B | $16.86B | $30.51B |
| Gross Margin | — | 47.5% | 60.0% | 57.1% | 56.1% |
| Operating Margin | — | 17.5% | 25.9% | 19.1% | 19.7% |
| Forward P/E | 285.2x | 17.9x | 14.4x | 18.0x | 12.6x |
| Total Debt | $0.00 | $609.53B | $942.38B | $475.56B | $365.90B |
| Cash & Equiv. | $1M | $164.26B | $343.34B | $111.69B | $231.84B |
FVN vs GS vs JPM vs MS vs BAC — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Nov 24 | Jun 26 | Return |
|---|---|---|---|
| Future Vision II Ac… (FVN) | 100 | 108.6 | +8.6% |
| The Goldman Sachs G… (GS) | 100 | 174.6 | +74.6% |
| JPMorgan Chase & Co. (JPM) | 100 | 128.4 | +28.4% |
| Morgan Stanley (MS) | 100 | 162.6 | +62.6% |
| Bank of America Cor… (BAC) | 100 | 117.9 | +17.9% |
Price return only. Dividends and distributions are not included.
Quick Verdict: FVN vs GS vs JPM vs MS vs BAC
Each card shows where this stock fits in a portfolio — not just who wins on paper.
FVN is the #2 pick in this set and the best alternative if sleep-well-at-night and defensive is your priority.
- Lower volatility, beta 0.02, current ratio 392.79x
- Beta 0.02, current ratio 392.79x
- 258.0% NII/revenue growth vs GS's -1.4%
- Beta 0.02 vs GS's 1.60
GS carries the broadest edge in this set and is the clearest fit for quality and momentum.
- Efficiency ratio 0.3% vs MS's 0.4% (lower = leaner)
- +72.7% vs FVN's +5.3%
- Efficiency ratio 0.3% vs MS's 0.4%
JPM is the clearest fit if your priority is valuation efficiency and bank quality.
- PEG 0.81 vs MS's 1.88
- NIM 2.2% vs FVN's 0.6%
MS is the clearest fit if your priority is growth exposure and long-term compounding.
- Rev growth 11.5%, EPS growth 28.3%
- 8.5% 10Y total return vs GS's 6.7%
BAC ranks third and is worth considering specifically for income & stability.
- Dividend streak 12 yrs, beta 0.86, yield 2.3%
- Lower P/E (12.6x vs 17.9x), PEG 0.82 vs 1.14
- 2.3% yield, 12-year raise streak, vs JPM's 1.9%, (1 stock pays no dividend)
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 258.0% NII/revenue growth vs GS's -1.4% | |
| Value | Lower P/E (12.6x vs 17.9x), PEG 0.82 vs 1.14 | |
| Quality / Margins | Efficiency ratio 0.3% vs MS's 0.4% (lower = leaner) | |
| Stability / Safety | Beta 0.02 vs GS's 1.60 | |
| Dividends | 2.3% yield, 12-year raise streak, vs JPM's 1.9%, (1 stock pays no dividend) | |
| Momentum (1Y) | +72.7% vs FVN's +5.3% | |
| Efficiency (ROA) | Efficiency ratio 0.3% vs MS's 0.4% |
FVN vs GS vs JPM vs MS vs BAC — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
FVN vs GS vs JPM vs MS vs BAC — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
JPM leads in 2 of 6 categories
BAC leads 1 • GS leads 1 • FVN leads 1 • MS leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
JPM leads this category, winning 4 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
JPM and FVN operate at a comparable scale, with $280.3B and $0 in trailing revenue. JPM is the more profitable business, keeping 20.4% of every revenue dollar as net income compared to GS's 13.7%.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $0 | $125.1B | $280.3B | $115.0B | $191.6B |
| EBITDAEarnings before interest/tax | $307,512 | $24.0B | $81.4B | $26.6B | $40.0B |
| Net IncomeAfter-tax profit | $288,024 | $17.2B | $57.0B | $16.9B | $30.5B |
| Free Cash FlowCash after capex | -$307,796 | -$47.2B | $100.9B | -$17.9B | $12.6B |
| Gross MarginGross profit ÷ Revenue | — | +47.5% | +60.0% | +57.1% | +56.1% |
| Operating MarginEBIT ÷ Revenue | — | +17.5% | +25.9% | +19.1% | +19.7% |
| Net MarginNet income ÷ Revenue | — | +13.7% | +20.4% | +14.7% | +15.9% |
| FCF MarginFCF ÷ Revenue | — | -37.7% | +36.0% | -15.6% | +6.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — | — | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | -3.7% | +45.8% | +16.0% | +48.9% | +18.3% |
Valuation Metrics
BAC leads this category, winning 5 of 7 comparable metrics.
Valuation Metrics
At 14.7x trailing earnings, BAC trades at a 95% valuation discount to FVN's 285.2x P/E. Adjusting for growth (PEG ratio), JPM offers better value at 0.90x vs MS's 2.19x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $82M | $337.5B | $896.0B | $341.0B | $422.8B |
| Enterprise ValueMkt cap + debt − cash | $81M | $782.8B | $1.50T | $704.8B | $556.8B |
| Trailing P/EPrice ÷ TTM EPS | 285.21x | 20.71x | 16.00x | 20.98x | 14.66x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 17.93x | 14.40x | 18.00x | 12.56x |
| PEG RatioP/E ÷ EPS growth rate | — | 1.32x | 0.90x | 2.19x | 0.95x |
| EV / EBITDAEnterprise value multiple | — | 32.57x | 18.36x | 26.49x | 13.92x |
| Price / SalesMarket cap ÷ Revenue | — | 2.70x | 3.20x | 2.97x | 2.21x |
| Price / BookPrice ÷ Book value/share | 34.72x | 2.70x | 2.47x | 3.03x | 1.39x |
| Price / FCFMarket cap ÷ FCF | — | — | 8.88x | 7.40x | 33.52x |
Profitability & Efficiency
JPM leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
JPM delivers a 15.9% return on equity — every $100 of shareholder capital generates $16 in annual profit, vs $1 for FVN. BAC carries lower financial leverage with a 1.21x debt-to-equity ratio, signaling a more conservative balance sheet compared to GS's 4.88x. On the Piotroski fundamental quality scale (0–9), MS scores 7/9 vs FVN's 2/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +0.9% | +13.6% | +15.9% | +15.3% | +10.1% |
| ROA (TTM)Return on assets | +0.5% | +1.0% | +1.3% | +1.2% | +0.9% |
| ROICReturn on invested capital | -0.9% | +2.2% | +4.5% | +3.1% | +3.5% |
| ROCEReturn on capital employed | -0.1% | +4.0% | +8.9% | +3.3% | +4.5% |
| Piotroski ScoreFundamental quality 0–9 | 2 | 5 | 5 | 7 | 7 |
| Debt / EquityFinancial leverage | — | 4.88x | 2.60x | 4.22x | 1.21x |
| Net DebtTotal debt minus cash | -$1M | $445.3B | $599.0B | $363.9B | $134.1B |
| Cash & Equiv.Liquid assets | $1M | $164.3B | $343.3B | $111.7B | $231.8B |
| Total DebtShort + long-term debt | $0 | $609.5B | $942.4B | $475.6B | $365.9B |
| Interest CoverageEBIT ÷ Interest expense | — | 0.33x | 0.74x | 0.45x | 0.48x |
Total Returns (Dividends Reinvested)
GS leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in GS five years ago would be worth $30,053 today (with dividends reinvested), compared to $10,928 for FVN. Over the past 12 months, GS leads with a +72.7% total return vs FVN's +5.3%. The 3-year compound annual growth rate (CAGR) favors GS at 48.1% vs FVN's 3.0% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +3.0% | +17.2% | -0.5% | +18.8% | +1.1% |
| 1-Year ReturnPast 12 months | +5.3% | +72.7% | +21.8% | +65.3% | +28.1% |
| 3-Year ReturnCumulative with dividends | +9.3% | +224.8% | +138.2% | +157.5% | +103.0% |
| 5-Year ReturnCumulative with dividends | +9.3% | +200.5% | +118.2% | +154.7% | +47.1% |
| 10-Year ReturnCumulative with dividends | +9.3% | +666.8% | +465.8% | +854.4% | +368.2% |
| CAGR (3Y)Annualised 3-year return | +3.0% | +48.1% | +33.6% | +37.1% | +26.6% |
Risk & Volatility
FVN leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
FVN is the less volatile stock with a 0.02 beta — it tends to amplify market swings less than GS's 1.60 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. FVN currently trades 99.8% from its 52-week high vs JPM's 95.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.02x | 1.60x | 0.94x | 1.40x | 0.86x |
| 52-Week HighHighest price in past year | $10.92 | $1095.89 | $337.25 | $219.16 | $57.55 |
| 52-Week LowLowest price in past year | $10.33 | $609.59 | $262.71 | $128.81 | $43.66 |
| % of 52W HighCurrent price vs 52-week peak | +99.8% | +97.0% | +95.1% | +97.7% | +97.3% |
| RSI (14)Momentum oscillator 0–100 | 60.5 | 57.3 | 59.1 | 62.2 | 68.3 |
| Avg Volume (50D)Average daily shares traded | 14K | 1.9M | 7.0M | 4.5M | 31.7M |
Analyst Outlook
Evenly matched — JPM and BAC each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: GS as "Hold", JPM as "Buy", MS as "Buy", BAC as "Buy". Consensus price targets imply 9.1% upside for BAC (target: $61) vs -8.5% for GS (target: $973). For income investors, BAC offers the higher dividend yield at 2.26% vs GS's 1.56%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Hold | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | — | $972.70 | $339.75 | $201.25 | $61.13 |
| # AnalystsCovering analysts | — | 55 | 61 | 52 | 54 |
| Dividend YieldAnnual dividend ÷ price | — | +1.6% | +1.9% | +1.9% | +2.3% |
| Dividend StreakConsecutive years of raises | — | 14 | 15 | 12 | 12 |
| Dividend / ShareAnnual DPS | — | $16.62 | $5.95 | $4.14 | $1.27 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +3.7% | +3.9% | +1.7% | +5.1% |
JPM leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). BAC leads in 1 (Valuation Metrics). 1 tied.
FVN vs GS vs JPM vs MS vs BAC: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is FVN or GS or JPM or MS or BAC a better buy right now?
For growth investors, Morgan Stanley (MS) is the stronger pick with 11.
5% revenue growth year-over-year, versus -1. 4% for The Goldman Sachs Group, Inc. (GS). Bank of America Corporation (BAC) offers the better valuation at 14. 7x trailing P/E (12. 6x forward), making it the more compelling value choice. Analysts rate JPMorgan Chase & Co. (JPM) a "Buy" — based on 61 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — FVN or GS or JPM or MS or BAC?
On trailing P/E, Bank of America Corporation (BAC) is the cheapest at 14.
7x versus Future Vision II Acquisition Corp. at 285. 2x. On forward P/E, Bank of America Corporation is actually cheaper at 12. 6x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: JPMorgan Chase & Co. wins at 0. 81x versus Morgan Stanley's 1. 88x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — FVN or GS or JPM or MS or BAC?
Over the past 5 years, The Goldman Sachs Group, Inc.
(GS) delivered a total return of +200. 5%, compared to +9. 3% for Future Vision II Acquisition Corp. (FVN). Over 10 years, the gap is even starker: MS returned +854. 4% versus FVN's +9. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — FVN or GS or JPM or MS or BAC?
By beta (market sensitivity over 5 years), Future Vision II Acquisition Corp.
(FVN) is the lower-risk stock at 0. 02β versus The Goldman Sachs Group, Inc. 's 1. 60β — meaning GS is approximately 6817% more volatile than FVN relative to the S&P 500. On balance sheet safety, Bank of America Corporation (BAC) carries a lower debt/equity ratio of 121% versus 5% for The Goldman Sachs Group, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — FVN or GS or JPM or MS or BAC?
By revenue growth (latest reported year), Morgan Stanley (MS) is pulling ahead at 11.
5% versus -1. 4% for The Goldman Sachs Group, Inc. (GS). On earnings-per-share growth, the picture is similar: Morgan Stanley grew EPS 28. 3% year-over-year, compared to -92. 4% for Future Vision II Acquisition Corp.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — FVN or GS or JPM or MS or BAC?
JPMorgan Chase & Co.
(JPM) is the more profitable company, earning 20. 4% net margin versus 0. 0% for Future Vision II Acquisition Corp. — meaning it keeps 20. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: JPM leads at 26. 0% versus 0. 0% for FVN. At the gross margin level — before operating expenses — JPM leads at 59. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is FVN or GS or JPM or MS or BAC more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, JPMorgan Chase & Co. (JPM) is the more undervalued stock at a PEG of 0. 81x versus Morgan Stanley's 1. 88x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Bank of America Corporation (BAC) trades at 12. 6x forward P/E versus 18. 0x for Morgan Stanley — 5. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for BAC: 9. 1% to $61. 13.
08Which pays a better dividend — FVN or GS or JPM or MS or BAC?
In this comparison, BAC (2.
3% yield), MS (1. 9% yield), JPM (1. 9% yield), GS (1. 6% yield) pay a dividend. FVN does not pay a meaningful dividend and should not be held primarily for income.
09Is FVN or GS or JPM or MS or BAC better for a retirement portfolio?
For long-horizon retirement investors, Future Vision II Acquisition Corp.
(FVN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 02)). The Goldman Sachs Group, Inc. (GS) carries a higher beta of 1. 60 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (FVN: +9. 3%, GS: +666. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between FVN and GS and JPM and MS and BAC?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: FVN is a small-cap quality compounder stock; GS is a large-cap quality compounder stock; JPM is a large-cap deep-value stock; MS is a large-cap quality compounder stock; BAC is a large-cap deep-value stock. GS, JPM, MS, BAC pay a dividend while FVN does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.